Listings on the PBS for Aboriginal and Torres Strait Islander people

Page last updated: 1 May 2016

The Australian Government is committed to improving the capability of the Pharmaceutical Benefits Scheme (PBS) to better meet the needs of Aboriginal and Torres Strait Islander people. The Pharmaceutical Benefits Advisory Committee is assisting this goal by evaluating and recommending the listing of medications specifically to help with the health needs of Aboriginal and Torres Strait Islander people.

This list details all PBS items that are limited for prescription to Aboriginal and Torres Strait Islander people. For more information about PBS access by Aboriginal and Torres Strait Islander people, see Improving the capacity of the PBS to meet particular Aboriginal and Torres Strait Islander health needs in the explanatory notes, or contact us at pbs-indigenous@health.gov.au.

 

Authority required (STREAMLINED)
3136 Nasal colonisation with Staphylococcus aureus in an Aboriginal or a Torres Strait Islander person.
Note:
No applications for increased maximum quantities and/or repeats will be authorised.

9440W Mupirocin, mupirocin 2% (20 mg/g) ointment, 3 g (Bactroban)

 

Restricted Benefit
Nicotine dependence
Clinical criteria:
The treatment must be the sole PBS-subsidised therapy for this condition.
Population criteria:
Patient must be an Aboriginal or a Torres Strait Islander person.
Note:
Only 2 courses of PBS-subsidised nicotine replacement therapy may be prescribed per 12-month period.
Benefit is improved if used in conjunction with a comprehensive support and counselling program.
Note:
No increase in the maximum quantity or number of units may be authorised.
Note:
No increase in the maximum number of repeats may be authorised.

5465P Nicotine, nicotine 21 mg/24 hours patch, 28 (Nicabate P)

5571F Nicotine, nicotine 21 mg/24 hours patch, 28 (Nicotinell Step 1)

10076H Nicotine, nicotine 25 mg/16 hours patch, 28 (nicorette 16hr Invisipatch)

 

Authority required
Treatment of a dermatophyte infection in an Aboriginal or a Torres Strait Islander person where topical treatment has failed

2285G Terbinafine, terbinafine 250 mg tablet, 42 (various brands)

 

Authority required (STREAMLINED)
2354 Treatment of a fungal or a yeast infection in an Aboriginal or a Torres Strait Islander person.

9024Y Ketoconazole, ketoconazole 2% (20 mg/g) cream, 30 g (Nizoral 2% Cream)

9025B Ketoconazole, ketoconazole 1% (10 mg/g) shampoo, 100 mL  (Nizoral 1%)

1574W Ketoconazole, ketoconazole 2% (20 mg/g) shampoo, 60 mL (Nizoral 2%)

9027D Miconazole, miconazole nitrate 2% (20 mg/g) cream, 30 g  (Daktarin)

9028E Miconazole, miconazole nitrate 2% (20 mg/g) cream, 70 g (Daktarin)

9029F Miconazole, miconazole nitrate 2% (20 mg/g) powder: dusting, 30 g (Daktarin)

9031H Miconazole, miconazole 2% solution, 30 mL (Daktarin)

1698J Nystatin, nystatin 100 000 international units/g cream, 15 g (Mycostatin)

9160D Terbinafine, terbinafine hydrochloride 1% cream, 15 g (Lamisil)

 

Authority required (STREAMLINED)
2384 Prophylaxis of thiamine deficiency in an Aboriginal or a Torres Strait Islander person

1070H ThiaminE, thiamine hydrochloride 100 mg tablet, 100 (Betamin)

 

Authority required (STREAMLINED)
2446 Treatment of whipworm infestation in an Aboriginal or Torres Strait Islander person

9047E Albendazole, albendazole 200 mg tablet: chewable, 6  (Zentel)

 

Authority Required
Treatment of chronic suppurative otitis media in an Aboriginal or a Torres Strait Islander person aged 1 month or older
Authority Required
Treatment of chronic suppurative otitis media in a patient less than 18 years of age with perforation of the tympanic membrane
Authority Required
Treatment of chronic suppurative otitis media in a patient less than 18 years of age with a grommet in situ

2480M Ciprofloxacin, ciprofloxacin 0.3% ear drops, 5 mL (Ciloxan)

 

Authority Required
Hypomagnesaemia in an Aboriginal or a Torres Strait Islander person;
Chronic renal disease in an Aboriginal or a Torres Strait Islander person.

5146W Magnesium, magnesium aspartate dihydrate 500 mg (equivalent to 37.4 mg of magnesium) tablet, 50 (Mag-Sup, MagMin (PBS))

 

The following items have been retained on the PBS General Schedule for treatment of patients identifying as Aboriginal or Torres Strait Islander origin. This is a result of the measure to delist certain over-the-counter (OTC) drugs from the PBS as part of the PBS Access and Sustainability package of measures. More information on this measure can be found on the PBS Access and Sustainability Package including the Sixth Community Pharmacy Agreement (see Removal of PBS Subsidy for certain Low-Cost, Over-The-Counter Medicines at page 16).      

 

Restricted benefit
For treatment of a patient identifying as Aboriginal or Torres Strait Islander        

2157M ALUMINIUM HYDROXIDE WITH MAGNESIUM HYDROXIDE, ALUMINIUM HYDROXIDE with MAGNESIUM HYDROXIDE Oral suspension 200 mg-200 mg per 5 mL, 500 mL, 1 (Mylanta P)

                               

Restricted benefit        
For treatment of a patient identifying as Aboriginal or Torres Strait Islander        

2014B ALGINATE SODIUM + CALCIUM CARBONATE + BICARBONATE, alginate sodium 500 mg/10 mL + calcium carbonate 160 mg/10 mL + sodium bicarbonate 267 mg/10 mL oral liquid, 500 mL (Gaviscon P)

               

Restricted benefit         
For treatment of a patient identifying as Aboriginal or Torres Strait Islander        

1010E ASPIRIN, aspirin 300 mg tablet: effervescent, 96 (Solprin)

5018D ASPIRIN, aspirin 300 mg tablet: effervescent, 96 (Solprin) (Dental)

8202Q ASPIRIN, aspirin 100 mg tablet, 112 (Spren 100)

 

Restricted benefit         
Constipation
Clinical criteria:
Patient must be paraplegic or quadriplegic or have severe neurogenic impairment of bowel function.

Restricted Benefit
Constipation
Clinical criteria:
Patient must be receiving palliative care.

Restricted Benefit
Constipation
Clinical criteria:
Patient must be receiving long-term nursing care on account of age, infirmity or other condition in a hospital, nursing home or residential facility.
Population criteria:
Patient must identify as Aboriginal or Torres Strait Islander.

Restricted Benefit
Constipation
Clinical criteria:
Patient must be receiving long-term nursing care and in respect of whom a Carer Allowance is payable as a disabled adult.
Population criteria:
Patient must identify as Aboriginal or Torres Strait Islander.

Restricted Benefit
Terminal malignant neoplasia
Population criteria:
Patient must identify as Aboriginal or Torres Strait Islander.

Restricted Benefit
Anorectal congenital abnormalities
Population criteria:
Patient must identify as Aboriginal or Torres Strait Islander.

Restricted Benefit
Megacolon
Population criteria:
Patient must identify as Aboriginal or Torres Strait Islander.     

1258F BISACODYL, bisacodyl 10 mg suppository, 12 (Petrus Bisacodyl Suppositories)

1260H BISACODYL, bisacodyl 10 mg suppository, 10 (Dulcolax, Petrus Bisacodyl Suppositories)

 

Restricted benefit      
For treatment of a patient identifying as Aboriginal or Torres Strait Islander      
Note:
Each sachet contains sodium chloride 470 mg, potassium chloride 300 mg, sodium acid citrate 530 mg and glucose 3.56 g.

3196F SODIUM CHLORIDE + POTASSIUM CHLORIDE + GLUCOSE MONOHYDRATE + CITRATE, sodium chloride 470 mg + potassium chloride 300 mg + glucose monohydrate 3.56 g + sodium acid citrate 530 mg oral liquid: powder for, 10 x 4.9 g sachets (Repalyte New Formulation, restore O.R.S.)

 

Restricted benefit         
For treatment of a patient identifying as Aboriginal or Torres Strait Islander       
Note
The 5 mg strength tablet should be used in malabsorption states only.

1437P FOLIC ACID, folic acid 5 mg tablet, 100 (Megafol 5)

 

Restricted benefit         
For treatment of a patient identifying as Aboriginal or Torres Strait Islander       

2958Q FOLIC ACID, folic acid 500 microgram tablet, 100 (Foltabs 500, Megafol 0.5)

 

Restricted benefit         
For treatment of a patient identifying as Aboriginal or Torres Strait Islander        

3106L GLUCOSE AND KETONE INDICATOR URINE, glucose and ketone indicator urine strip: diagnostic, 50 diagnostic strips (Keto-Diabur- Test 5000)

3107M GLUCOSE AND KETONE INDICATOR URINE, glucose and ketone indicator urine strip: diagnostic, 50 diagnostic strips (Keto-Diastix)

3104J GLUCOSE INDICATOR URINE, glucose indicator urine strip: diagnostic, 50 diagnostic strips (Diastix)

 

Restricted Benefit        
Pernicious anaemia
Population criteria:
Patient must identify as Aboriginal or Torres Strait Islander.

Restricted Benefit
Proven vitamin B12 deficiencies other than pernicious anaemia
Population criteria:
Patient must identify as Aboriginal or Torres Strait Islander.

Restricted Benefit
Anaemias associated with vitamin B12 deficiency
Clinical criteria:
Patient must have had a gastrectomy,
AND
The treatment must be for prophylaxis.
Population criteria:
Patient must identify as Aboriginal or Torres Strait Islander.

Note
One injection of hydroxocobalamin 1 mg every three months provides appropriate maintenance therapy in vitamin B12 deficiencies.
Note
Pharmaceutical benefits that have the form hydroxocobalamin injection 1 mg (as acetate) in 1 mL and pharmaceutical benefits that have the form hydroxocobalamin injection 1 mg (as chloride) in 1 mL are equivalent for the purposes of substitution.

2162T HYDROXOCOBALAMIN, hydroxocobalamin 1 mg/mL injection, 3 x 1 mL ampoules (Vita-B12)

9048F HYDROXOCOBALAMIN, hydroxocobalamin 1 mg/mL injection, 3 x 1 mL ampoules (Neo-B12)

               

Restricted Benefit         
For treatment of a patient identifying as Aboriginal or Torres Strait Islander        

1746X PARACETAMOL, paracetamol 500 mg tablet, 100 (APO-Paracetamol, Febridol, Generic Health Pty Ltd, Panamax, Paracetamol (Sandoz), Paralgin, Parapane)

5196L PARACETAMOL, paracetamol 500 mg tablet, 100 (APO-Paracetamol, Febridol, Generic Health Pty Ltd, Panamax, Paracetamol (Sandoz), Paralgin, Parapane) (Dental)

               

Restricted Benefit        
Chronic arthropathies
Population criteria:
Patient must identify as Aboriginal or Torres Strait Islander.

5224Y PARACETAMOL, paracetamol 500 mg tablet, 100 (APO-Paracetamol, Febridol, Generic Health Pty Ltd, Panamax, Paracetamol (Sandoz), Paralgin, Parapane) (Dental)

8784H PARACETAMOL, paracetamol 500 mg tablet, 100 (APO-Paracetamol, Febridol, Generic Health Pty Ltd, Panamax, Paracetamol (Sandoz), Paralgin, Parapane)

               

Restricted Benefit         
Persistent pain
Clinical criteria:
The condition must be associated with osteoarthritis.   
Population criteria:
Patient must identify as Aboriginal or Torres Strait Islander.     
   

8814X PARACETAMOL, paracetamol 665 mg tablet: modified release, 96 tablets (Osteomol 665 Paracetamol)

 

Restricted Benefit         
For treatment of a patient identifying as Aboriginal or Torres Strait Islander        

1747Y PARACETAMOL, paracetamol 120 mg/5 mL oral liquid, 100 mL (Panamax)

1770E PARACETAMOL, paracetamol 240 mg/5 mL oral liquid, 200 mL (Panamax 240 Elixir)

3348F PARACETAMOL, paracetamol 120 mg/5 mL oral liquid, 100 mL (Panamax) (Dental)

3349G PARACETAMOL, paracetamol 240 mg/5 mL oral liquid, 200 mL (Panamax 240 Elixir) (Dental)